[go: up one dir, main page]

CS257789B2 - Method of contaminated peptic or protein products purifying acquired by means of rdna technics - Google Patents

Method of contaminated peptic or protein products purifying acquired by means of rdna technics Download PDF

Info

Publication number
CS257789B2
CS257789B2 CS853684A CS368485A CS257789B2 CS 257789 B2 CS257789 B2 CS 257789B2 CS 853684 A CS853684 A CS 853684A CS 368485 A CS368485 A CS 368485A CS 257789 B2 CS257789 B2 CS 257789B2
Authority
CS
Czechoslovakia
Prior art keywords
product
contaminated
contaminants
lps
humulin
Prior art date
Application number
CS853684A
Other languages
Czech (cs)
English (en)
Other versions
CS368485A2 (en
Inventor
Stefan Svenson
Original Assignee
Stefan Svenson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stefan Svenson filed Critical Stefan Svenson
Publication of CS368485A2 publication Critical patent/CS368485A2/cs
Publication of CS257789B2 publication Critical patent/CS257789B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/42—Electrodialysis; Electro-osmosis ; Electro-ultrafiltration; Membrane capacitive deionization
    • B01D61/44—Ion-selective electrodialysis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/04—Specific process operations in the feed stream; Feed pretreatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Water Supply & Treatment (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CS853684A 1984-05-28 1985-05-22 Method of contaminated peptic or protein products purifying acquired by means of rdna technics CS257789B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8402861A SE8402861L (sv) 1984-05-28 1984-05-28 Rening av biologiskt material

Publications (2)

Publication Number Publication Date
CS368485A2 CS368485A2 (en) 1987-11-12
CS257789B2 true CS257789B2 (en) 1988-06-15

Family

ID=20356050

Family Applications (1)

Application Number Title Priority Date Filing Date
CS853684A CS257789B2 (en) 1984-05-28 1985-05-22 Method of contaminated peptic or protein products purifying acquired by means of rdna technics

Country Status (20)

Country Link
US (1) US4746647A (no)
EP (1) EP0185700A1 (no)
JP (1) JPS61502378A (no)
KR (1) KR860700135A (no)
AU (1) AU4435885A (no)
BR (1) BR8506758A (no)
CS (1) CS257789B2 (no)
DD (1) DD241748A5 (no)
DK (1) DK39786A (no)
ES (3) ES8609474A1 (no)
FI (1) FI860316A0 (no)
HU (1) HUT39774A (no)
IL (1) IL75258A0 (no)
IN (1) IN162119B (no)
NO (1) NO860295L (no)
NZ (1) NZ212155A (no)
PL (1) PL253664A1 (no)
SE (1) SE8402861L (no)
WO (1) WO1985005631A1 (no)
ZA (1) ZA853918B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986002068A1 (en) * 1984-09-26 1986-04-10 Takeda Chemical Industries, Ltd. Mutual separation of proteins
DE3526096A1 (de) * 1985-07-22 1987-01-22 Basf Ag Verfahren zur reinigung von htnf
US4894439A (en) * 1986-05-22 1990-01-16 Cetus Corporation N-terminal derivatives of tumor necrosis factor purified by microporous PTFE membranes
US4798886A (en) * 1986-03-24 1989-01-17 Takeda Chemical Industries, Ltd. Mutual separation of proteins
JPH0789951B2 (ja) * 1986-06-18 1995-10-04 財団法人阪大微生物病研究会 遺伝子発現産物の精製法
US4940456A (en) * 1987-02-10 1990-07-10 Dan Sibalis Electrolytic transdermal delivery of proteins
DE3724442A1 (de) * 1987-07-23 1989-02-02 Europ Lab Molekularbiolog Verfahren und vorrichtung zur reinigung von m-13-phagen-dna
US5147779A (en) * 1988-06-01 1992-09-15 Miles Inc. Method for evaluating immunogenicity
AUPP521298A0 (en) * 1998-08-12 1998-09-03 Life Therapeutics Limited Purification of fibrinogen
US20050224355A1 (en) * 1999-12-23 2005-10-13 Brendon Conlan Removal of biological contaminants
AUPP790898A0 (en) 1998-12-23 1999-01-28 Life Therapeutics Limited Renal dialysis
AUPP790698A0 (en) * 1998-12-23 1999-01-28 Life Therapeutics Limited Separation of microorganisms
AUPP971399A0 (en) 1999-04-12 1999-05-06 Life Therapeutics Limited Separation of plasma components
US7077942B1 (en) * 1999-12-23 2006-07-18 Gradipore Limited Removal of biological contaminants
AUPQ691400A0 (en) 2000-04-14 2000-05-11 Life Therapeutics Limited Separation of micromolecules
AUPQ697300A0 (en) 2000-04-18 2000-05-11 Life Therapeutics Limited Separation apparatus
DE60140537D1 (de) 2000-04-18 2009-12-31 Gradipore Ltd Trennung und behandlung von proben durch elektrophorese
US6923896B2 (en) * 2000-09-22 2005-08-02 The Texas A&M University System Electrophoresis apparatus and method
EP1341596B1 (en) * 2000-10-06 2010-07-07 Arturus Capital Limited Multi-port electrophoresis separation apparatus and corresponding method
AUPR222300A0 (en) * 2000-12-21 2001-01-25 Life Therapeutics Limited Electrophoresis device and method
US20030232401A1 (en) * 2002-06-12 2003-12-18 Pugia Michael J. Bacterial test method by glycated label binding
GB201204756D0 (en) * 2012-03-19 2012-05-02 Lewi Paulus J Triazines with suitable spacers for treatment and/or prevention of HIV infections

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1188519A (en) * 1966-10-27 1970-04-15 Wellcome Found Method for the Purification of Lipopolysaccharides
US4185090A (en) * 1972-02-02 1980-01-22 Abbott Laboratories Chemically modified endotoxin immunizing agent
SE7804098L (sv) * 1977-04-20 1978-10-21 R & Z Vermoegensverw Gmbh Peptidkomplex fran dna-haltiga organismer
US4276140A (en) * 1980-01-10 1981-06-30 Ionics Inc. Electrodialysis apparatus and process for fractionating protein mixtures
US4321192A (en) * 1980-01-10 1982-03-23 Ionics Incorporated Fractionation of protein mixtures by salt addition followed by dialysis treatment
US4426323A (en) * 1980-01-10 1984-01-17 Ionics, Incorporated Selected recovery of proteins from fermentation broths
US4351710A (en) * 1980-01-10 1982-09-28 Ionics, Incorporated Fractionation of protein mixtures
US4322275A (en) * 1980-01-10 1982-03-30 Ionics Incorporated Fractionation of protein mixtures
SE8205892D0 (sv) * 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
JPS6078999A (ja) * 1983-10-05 1985-05-04 Chemo Sero Therapeut Res Inst ＨＢｓ抗原の精製方法
JPS61103895A (ja) * 1984-10-26 1986-05-22 Green Cross Corp:The ＨＢｓＡｇの精製方法

Also Published As

Publication number Publication date
BR8506758A (pt) 1986-09-23
KR860700135A (ko) 1986-03-31
ES8802584A1 (es) 1988-08-01
ES8609474A1 (es) 1986-08-01
SE8402861L (sv) 1985-11-29
CS368485A2 (en) 1987-11-12
SE8402861D0 (sv) 1984-05-28
ES8802583A1 (es) 1988-08-01
EP0185700A1 (en) 1986-07-02
ES543512A0 (es) 1986-08-01
HUT39774A (en) 1986-10-29
DD241748A5 (de) 1986-12-24
DK39786D0 (da) 1986-01-27
ZA853918B (en) 1986-01-29
PL253664A1 (en) 1986-02-11
JPS61502378A (ja) 1986-10-23
US4746647A (en) 1988-05-24
AU4435885A (en) 1985-12-31
NZ212155A (en) 1988-10-28
FI860316A (fi) 1986-01-22
DK39786A (da) 1986-01-27
NO860295L (no) 1986-01-28
ES552518A0 (es) 1988-08-01
ES552519A0 (es) 1988-08-01
IL75258A0 (en) 1985-09-29
FI860316A0 (fi) 1986-01-22
IN162119B (no) 1988-04-02
WO1985005631A1 (en) 1985-12-19

Similar Documents

Publication Publication Date Title
CS257789B2 (en) Method of contaminated peptic or protein products purifying acquired by means of rdna technics
Lutz et al. Naturally occurring autoantibodies to skeletal proteins from human red blood cells.
Kay et al. Senescent cell antigen is immunologically related to band 3.
Sachs et al. Antibodies to a distinct antigenic determinant of staphylococcal nuclease
US7038017B2 (en) Antibody purification
US20100186100A1 (en) Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84
EP0453767A1 (en) Improved method for purification of monoclonal antibodies
Rozzo et al. Purification of transfer factors
Shih et al. Antigenicity of the major polypeptides of hepatitis B surface antigen (HBsAg)
Sheng et al. β2-glycoprotein I: Target antigen for ‘antiphospholipid’antibodies. Immunological and molecular aspects
JPH09505811A (ja) チャペロニン１０のアンタゴニスト
Sparks et al. The production and utility of monoclonal antibodies to rat apolipoprotein B lipoproteins
EP0331186B1 (en) Monoclonal antibody selectively binding to novel g-csf derivative
Andersson et al. C-terminal-specific monoclonal antibodies against the human red cell glucose transporter. Epitope localization with synthetic peptides.
Thammana et al. Immunoglobulin heavy chain class switch from IgM to IgG in a hybridoma
JPH07238096A (ja) 抗ポリユビキチン・モノクローナル抗体およびポリユビキチンの測定方法
Fang et al. Physiochemical characterization of proteolytic cleavage fragments of bovine colostral immunoglobulin G1 (IgG1)
Urbain et al. Sharing of idiotypic specificities between different antibody populations from an individual rabbit
US7226749B2 (en) Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
Marchalonis et al. 7S immunoglobulins of a monotreme, the echidna Tachyglossus aculeatus: two distinct isotypes which bind A protein of Staphylococcus aureus
US5430129A (en) Purified, native dystrophin
EP1101772B1 (en) Antibody specific to interleukin 18 precursor
Muller et al. [12] Use of antihistone antibodies with nucleosomes
Kuzmanoff et al. Isolation of monoclonal antibodies monospecific for bovine β-lactoglobulin
Bluestone et al. Anti-idiotypes against anti-H-2 monoclonal antibodies: structural analysis of the molecules induced by in vivo anti-idiotype treatment.